《美股業績》Intel上季蝕6.6億美元 績遜市後股價挫7%
Intel(INTC.US)公佈, 隨疫情過去,個人電腦銷售回落,公司銷售下滑幅度大過預期,去年第四季度收入140.4億美元,低於市場預期144.5億美元。第四季度虧損6.64億美元,每股虧損16美分,而去年同期的淨收入爲46.2億美元,每股收益1.13美元。調整後每股收益0.1美仙,低於市場預期的20美仙。
公司盈收遜預期,股價於市後交易時段下跌超過7%。過去12個月,Intel股價累跌43%。
Intel預期,第一季調整後每股虧損15美分,收入約爲105億美元至115億美元,調整後毛利率約爲39%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.